Eli Lilly and Co says John Johnson will lead the oncology business unit. Johnson currently serves as chief executive officer of ImClone Systems. Lilly also announced that Enrique Conterno will lead the diabetes business unit, Bryce Carmine will lead the established markets business unit and Jeffrey Simmons will lead Elanco, the animal health business unit. The new roles will become effective on Nov. 1, 2009.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
